Purpose: The purpose of this study is to assess the baseline serum cholinesterase level (ChE) as a predictor of survival in a retrospective cohort of elderly patients with treatment naive hepatocellular carcinoma (HCC) treated with proton beam therapy (PBT). The gene discussed is BCHE; the disease is hepatocellular carcinoma.